# IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

> **NCT04205266** · PHASE4 · UNKNOWN · sponsor: **Thomas Jefferson University** · enrollment: 76 (estimated)

## Conditions studied

- Anemia, Iron Deficiency
- Heavy Menstrual Bleeding

## Interventions

- **DRUG:** Ferumoxytol
- **DRUG:** Ferrous Sulfate

## Key facts

- **NCT ID:** NCT04205266
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-14
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2023-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04205266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04205266, "IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04205266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*